Eloxx Pharmaceuticals, Inc.
Ownership
Ownership Structure
Who owns Eloxx Pharmaceuticals, Inc. (ELOX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 27.1% of the shares are freely tradable; institutional investors hold 81.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 23.28 | 800,000 | +0.0 | 06/30/2026 |
| EcoR1 Capital, LLC | 11.64 | 400,000 | +0.0 | 06/30/2026 |
| Siren, L.L.C. | 11.64 | 400,000 | +0.0 | 06/30/2026 |
| Samsara BioCapital, LLC | 11.64 | 400,000 | +0.0 | 06/30/2026 |
| Aberdeen Group PLC | 11.64 | 400,000 | +0.0 | 06/30/2026 |
| Stonepine Capital Management Llc | 11.56 | 397,160 | +0.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 2.29 | 78,680 | +0.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| abrdn Healthcare Investors | 7.83 | 269,100 | +0.0 | 08/31/2026 |
| abrdn Life Sciences Investors | 3.81 | 130,900 | +0.0 | 08/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.67 | 57,476 | +0.0 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.